Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
Gauting, Germany
Oncologist in Gauting, Bavaria
Asklepios Fachkliniken München-Gauting, Robert-Koch-Allee 2, 82131 Gauting
About Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Genentech, Inc.
1
Clinical Trials at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
During the past decade, Asklepios-Fachkliniken Muenchen-Gauting; Onkologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
2012-01-20
2016-03-30
Completed
501
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"
2013-08-06
2018-09-06
Completed
287
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
2014-12-15
2018-08-20
Completed
49
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib
2015-11-03
2018-08-13
Completed
119
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
2018-04-24
2025-01-19
Active, not recruiting
453
The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy
2018-05-30
2023-05-30
Active, not recruiting
359
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
2020-07-24
2026-06-25
Recruiting
226
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
According to Clinical.Site data, the most researched conditions in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" are
"Non-Small Cell Lung Cancer" (3 trials), "Adenocarcinoma" (1 trials), "Bronchial Diseases" (1 trials), "Carcinoma" (1 trials) and "Carcinoma, Bronchogenic" (1 trials). Many other conditions were trialed in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
Most popular intervention types in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Docetaxel" (3 trials), "Pemetrexed" (3 trials), "Carboplatin" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
The vast majority of trials in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" are
8 trials for "All" genders.
Clinical Trials Status at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
Currently, there are NaN active trials in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Asklepios-Fachkliniken Muenchen-Gauting; Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios-Fachkliniken Muenchen-Gauting; Onkologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".